A Proposal from the Montpellier World Health Organization Collaborating Centre for Better Management and Prevention of Anaphylaxis

Food‐induced anaphylaxis morbidity: Emergency department and hospitalization data support preventive strategies

“…Recently, the definition of anaphylaxis was reviewed by the WAO in order to capture not only severe cases but also align with the anaphylaxis definition proposed in the WHO ICD‐11: ‘Anaphylaxis is a severe, life‐threatening systemic hypersensitivity reaction characterized by being rapid in onset with potentially life‐threatening airway, breathing, or circulatory problems and is usually, although not always, associated with skin and mucosal changes or circulatory shock’ 30,45,46 . This can support for instance the appropriate treatment of FIA manifested by skin and gastrointestinal symptoms, which would not be termed anaphylaxis if we applied the previous definition.…”

“…Our WHO CC provides the means though which governmental and nongovernmental collaborating parties can align their strengths to achieve focused objectives, such as putting in place the global initiative against anaphylaxis. 30 Since the availability of AAIs is limited to only 32% of world countries, our WHO CC is leading the initiative to achieve global availability of AAIs. 8 This study however presents some limitations.…”

“…Recommendations for follow‐up and trigger avoidance at the time of discharge from the ED are provided infrequently putting the patient in danger. In order to strengthen the healthcare pathways and optimize the patients’ time across the heath system, the EAACI Logogram task force together with the Montpellier WHO Collaborating Centre leadership are moving efforts at national and international levels in order to implement actions and collaboration among specialists 30 …”

“…Extended international actions are supported by the WHO‐FIC, academic and scientific networks, the Joint Allergy Academies, stakeholders and patient's organizations. Our WHO CC provides the means though which governmental and nongovernmental collaborating parties can align their strengths to achieve focused objectives, such as putting in place the global initiative against anaphylaxis 30 . Since the availability of AAIs is limited to only 32% of world countries, our WHO CC is leading the initiative to achieve global availability of AAIs 8…”

“…In order to strengthen the healthcare pathways and optimize the patients' time across the heath system, the EAACI Logogram task force together with the Montpellier WHO Collaborating Centre leadership are moving efforts at national and international levels in order to implement actions and collaboration among specialists. 30 With the aim of trying to standardize management of anaphylaxis and promote quality care, the allergy academies have been moving efforts to provide guidance. 6,23,[31][32][33][34][35][36] The WAO anaphylaxis committee has just provided a great piece of work to support a better management of anaphylaxis in different world regions.…”